a month ago
TNYA
AnalystsMatthew HarrisonMatthew Harrison's Stock Forecasts
AnalystsMatthew Harrison
Analyst Ranking
Bottom 24%
#3752 out of 4861 analysts
Average Return
-0.06%
Win Rate
47%158 out of 335
Risk vs Reward
Poor
Good
Matthew Harrison's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Moderna IncMRNA | +267.87% | $37.25 | $137.03 | 2020-04-15 - 2020-12-16 | Strong Buy |
Fusion Pharmaceuticals IncFUSN | +235.08% | $3.25 | $10.89 | 2023-01-27 - 2024-01-26 | Strong Buy |
Insmed IncINSM | +226.56% | $21.99 | $71.81 | 2023-08-04 - 2024-08-02 | Strong Buy |
Loxo Oncology IncLOXO | +185.28% | $43.47 | $124.01 | 2017-04-03 - 2018-03-21 | Strong Buy |
Denali Therapeutics IncDNLI | +180.06% | $20.01 | $56.04 | 2020-04-15 - 2021-04-15 | Strong Buy |
Matthew Harrison Analyst Color
Get additional color on Matthew Harrison's coverage of popular stocks
a month ago
GILD
2 months ago
LYV
2 months ago
GILD
3 months ago
CMCSA
3 months ago
GILD
7 months ago
IOBT
9 months ago
INSM
2 years ago
MRNA
2 years ago
MRNA
3 years ago
ABBV
3 years ago
PFE
3 years ago
PFE
3 years ago
ABBV
4 years ago
PFE
4 years ago
MRK
Matthew Harrison's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Sarepta Therapeutics IncSRPT | 24 | Strong Buy | $182.00 | +238.35% | Maintains | 10 days ago |
Atea Pharmaceuticals IncAVIR | 9 | Hold | $6.00 | +102.02% | Maintains | 10 days ago |
Biogen IncBIIB | 31 | Hold | $152.00 | +28.15% | Maintains | 12 days ago |
Moderna IncMRNA | 18 | Hold | $32.00 | +29.48% | Maintains | 12 days ago |
Legend Biotech CorpLEGN | 8 | Strong Buy | $80.00 | +143.90% | Maintains | a month ago |
2seventy Bio IncTSVT | 9 | Hold | $5.00 | +0.40% | Maintains | a month ago |
Tenaya Therapeutics IncTNYA | 4 | Strong Buy | $5.00 | +1,011.11% | Maintains | a month ago |
Gilead Sciences IncGILD | 28 | Strong Buy | $130.00 | +24.35% | Maintains | a month ago |
Denali Therapeutics IncDNLI | 8 | Strong Buy | $33.00 | +159.03% | Assumes | a month ago |
Live Nation Entertainment IncLYV | 1 | Strong Buy | $178.00 | +39.92% | Maintains | 2 months ago |
Avient CorpAVNT | 1 | Buy | $56.00 | +79.49% | Upgrades | 2 months ago |
Vertex Pharmaceuticals IncVRTX | 19 | Hold | $459.00 | -6.15% | Maintains | 2 months ago |
Insmed IncINSM | 11 | Strong Buy | $90.00 | +23.88% | Maintains | 2 months ago |
Comcast CorpCMCSA | 2 | Strong Buy | $55.00 | +61.72% | Maintains | 3 months ago |
Alector IncALEC | 7 | Strong Sell | $3.00 | +226.09% | Downgrades | 5 months ago |
Regeneron Pharmaceuticals IncREGN | 28 | Strong Buy | $1,184.00 | +110.24% | Maintains | 6 months ago |
Io Biotech IncIOBT | 5 | Strong Buy | $6.00 | +597.67% | Maintains | 7 months ago |
Centessa Pharmaceuticals PLCCNTA | 9 | Hold | $11.00 | -10.53% | Maintains | 10 months ago |
Zentalis Pharmaceuticals IncZNTL | 4 | Hold | $8.00 | +520.16% | Downgrades | 10 months ago |
Argenx SeARGX | 10 | Strong Buy | $510.00 | -14.46% | Maintains | a year ago |
Editas Medicine IncEDIT | 9 | Hold | $7.00 | +446.88% | Upgrades | a year ago |
Biomarin Pharmaceutical IncBMRN | 17 | Strong Buy | $112.00 | +89.29% | Maintains | a year ago |
Pharvaris NvPHVS | 14 | Strong Buy | $34.00 | +142.86% | Maintains | a year ago |
Genmab AGMAB | 18 | Strong Sell | $32.00 | N/A | Maintains | a year ago |
Cerevel Therapeutics Holdings IncCERE | 6 | Strong Buy | $38.00 | N/A | Maintains | a year ago |
Barinthus Biotherapeutics PLCBRNS | 5 | Hold | $3.25 | N/A | Downgrades | 2 years ago |
Beigene LtdONC | 11 | Strong Buy | $319.00 | N/A | Maintains | 2 years ago |
Prime Medicine IncPRME | 3 | Hold | $19.00 | N/A | Maintains | 2 years ago |
Seagen IncSGEN | 15 | Hold | $229.00 | N/A | Reiterates | 2 years ago |
Bluebird Bio IncBLUE | 28 | Strong Sell | $60.00 | N/A | Reiterates | 2 years ago |
Sigilon Therapeutics IncSGTX | 7 | Hold | $21.00 | N/A | Maintains | 2 years ago |
Vigil Neuroscience IncVIGL | 3 | Hold | $13.00 | N/A | Maintains | 2 years ago |
Invivyd IncIVVD | 7 | Strong Sell | $1.00 | N/A | Maintains | 2 years ago |
Innoviva IncINVA | 7 | Strong Sell | $10.00 | N/A | Maintains | 2 years ago |
Fulcrum Therapeutics IncFULC | 7 | Hold | $8.00 | N/A | Downgrades | 2 years ago |
Galapagos NvGLPG | 14 | Hold | $44.00 | N/A | Maintains | 2 years ago |
Fusion Pharmaceuticals IncFUSN | 3 | Strong Buy | $10.00 | N/A | Maintains | 2 years ago |
Sana Biotechnology IncSANA | 2 | Strong Buy | $13.00 | N/A | Maintains | 2 years ago |
Lyell Immunopharma IncLYEL | 3 | Hold | $4.00 | N/A | Maintains | 2 years ago |
Bolt Biotherapeutics IncBOLT | 3 | Hold | $3.00 | N/A | Maintains | 2 years ago |
Biontech SeBNTX | 6 | Hold | $216.00 | N/A | Maintains | 2 years ago |
Adc Therapeutics SaADCT | 8 | Hold | $5.00 | N/A | Maintains | 2 years ago |
Adagene IncADAG | 5 | Strong Buy | $5.00 | N/A | Maintains | 2 years ago |
Abbvie IncABBV | 7 | Strong Buy | $182.00 | N/A | Maintains | 2 years ago |
Kodiak Sciences IncKOD | 5 | Hold | $9.00 | N/A | Maintains | 2 years ago |
Akero Therapeutics IncAKRO | 5 | Hold | $40.00 | N/A | Maintains | 2 years ago |
Amgen IncAMGN | 20 | Strong Buy | $282.00 | N/A | Maintains | 2 years ago |
Alnylam Pharmaceuticals IncALNY | 6 | Hold | $210.00 | N/A | Maintains | 2 years ago |
Kalaris Therapeutics IncKLRS | 7 | Strong Buy | $621.00 | N/A | Maintains | 3 years ago |
Johnson & JohnsonJNJ | 3 | Hold | $173.00 | N/A | Maintains | 3 years ago |
Pfizer IncPFE | 4 | Hold | $55.00 | N/A | Maintains | 3 years ago |
Merck & Co IncMRK | 4 | Hold | $82.00 | N/A | Maintains | 3 years ago |
Biohaven Pharmaceutical Holding Co LtdBHVN1 | 8 | Hold | $145.00 | N/A | Maintains | 4 years ago |
Kaleido Biosciences IncKLDO | 3 | Strong Sell | $3.00 | N/A | Downgrades | 4 years ago |
Sage Therapeutics IncSAGE | 3 | Hold | $78.00 | N/A | Maintains | 4 years ago |
Bristol Myers Squibb CoBMY | 2 | Hold | $66.00 | N/A | Maintains | 4 years ago |
Taysha Gene Therapies IncTSHA | 2 | Strong Buy | $39.00 | N/A | Maintains | 4 years ago |
Royalty Pharma PLCRPRX | 1 | Hold | $46.00 | N/A | Maintains | 4 years ago |
Organon & CoOGN | 1 | Hold | $35.00 | N/A | Maintains | 4 years ago |
Enliven Therapeutics IncELVN | 3 | Hold | $12.00 | N/A | Downgrades | 4 years ago |
Eli Lilly & CoLLY | 1 | Strong Buy | $275.00 | N/A | Maintains | 4 years ago |
Grupo Televisa SabTV | 1 | Strong Buy | $19.00 | N/A | Initiates Coverage On | 4 years ago |
Evelo Biosciences IncEVLO | 7 | Hold | $260.00 | N/A | Maintains | 4 years ago |
Freeline Therapeutics Holdings PLCFRLN | 2 | Strong Buy | $330.00 | N/A | Maintains | 4 years ago |
Regenxbio IncRGNX | 4 | Strong Buy | $62.00 | N/A | Maintains | 4 years ago |
Huntington Bancshares IncHBAN | 1 | Hold | $17.25 | N/A | Maintains | 4 years ago |
Unity Biotechnology IncUBX | 4 | Hold | $50.00 | N/A | Downgrades | 5 years ago |
Immunomedics IncIMMU | 1 | Hold | $22.00 | N/A | Maintains | 5 years ago |
Global Blood Therapeutics IncGBT | 6 | Hold | $70.00 | N/A | Maintains | 5 years ago |
Alexion Pharmaceuticals IncALXN | 9 | Hold | $116.00 | N/A | Maintains | 5 years ago |
Rubius Therapeutics IncRUBY | 1 | Hold | $4.00 | N/A | Downgrades | 5 years ago |
Forty Seven IncFTSV | 2 | Hold | $95.50 | N/A | Downgrades | 5 years ago |
Incyte CorpINCY | 1 | Hold | $83.00 | N/A | Maintains | 5 years ago |
Ultragenyx Pharmaceutical IncRARE | 4 | Strong Buy | $83.00 | N/A | Upgrades | 6 years ago |
Celgene CorpCELG | 8 | Hold | $88.00 | N/A | Maintains | 6 years ago |
Radius Health IncRDUS1 | 4 | Strong Buy | $57.00 | N/A | Maintains | 7 years ago |
Portola Pharmaceuticals IncPTLA | 6 | Hold | $32.00 | N/A | Maintains | 7 years ago |
Loxo Oncology IncLOXO | 6 | Strong Buy | $213.00 | N/A | Maintains | 7 years ago |
Cytokinetics IncCYTK | 4 | Hold | $10.00 | N/A | Assumes | 7 years ago |
Bioverativ IncBIVV | 2 | Hold | N/A | N/A | Upgrades | 7 years ago |
Juno Therapeutics IncJUNO | 1 | Hold | $43.00 | N/A | Maintains | 8 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.